Susanna M. Rybak

2.2k total citations
54 papers, 1.8k citations indexed

About

Susanna M. Rybak is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susanna M. Rybak has authored 54 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 23 papers in Immunology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susanna M. Rybak's work include Monoclonal and Polyclonal Antibodies Research (21 papers), Toxin Mechanisms and Immunotoxins (17 papers) and Glycosylation and Glycoproteins Research (12 papers). Susanna M. Rybak is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), Toxin Mechanisms and Immunotoxins (17 papers) and Glycosylation and Glycoproteins Research (12 papers). Susanna M. Rybak collaborates with scholars based in United States, Germany and Colombia. Susanna M. Rybak's co-authors include Dianne L. Newton, James W. Fett, Bert L. Vallée, Michaela A.E. Arndt, Karen A. Olson, Stanislaw M. Mikulski, Mihail S. Iordanov, Bruce E. Magun, David M. Goldenberg and Hans J. Hansen and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Molecular Biology.

In The Last Decade

Susanna M. Rybak

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susanna M. Rybak United States	27	1.1k	559	423	200	189	54	1.8k
S.M. Rybak United States	19	830 0.7×	417 0.7×	272 0.6×	106 0.5×	208 1.1×	29	1.2k
Kuslima Shogen United States	23	1.2k 1.1×	295 0.5×	90 0.2×	160 0.8×	200 1.1×	47	1.7k
Chun Jeih Ryu South Korea	26	1.1k 1.0×	337 0.6×	233 0.6×	430 2.1×	136 0.7×	78	1.9k
Aaron K. Sato United States	22	1.5k 1.3×	643 1.2×	783 1.9×	697 3.5×	135 0.7×	41	2.5k
C. Deborah Wilde United Kingdom	13	1.5k 1.3×	548 1.0×	887 2.1×	176 0.9×	82 0.4×	14	2.3k
Behjatolah Monzavi‐Karbassi United States	21	885 0.8×	549 1.0×	305 0.7×	207 1.0×	99 0.5×	63	1.3k
Detlef Güssow Germany	11	1.4k 1.2×	640 1.1×	1.3k 3.1×	206 1.0×	131 0.7×	15	2.1k
Paolo Monaci Italy	28	1.9k 1.7×	464 0.8×	929 2.2×	315 1.6×	76 0.4×	53	2.8k
Polly D. Gregor United States	17	1.1k 1.0×	822 1.5×	165 0.4×	322 1.6×	144 0.8×	28	2.0k
Robert M. Kay United States	18	1.3k 1.2×	782 1.4×	565 1.3×	406 2.0×	151 0.8×	18	2.6k

Countries citing papers authored by Susanna M. Rybak

Since Specialization

Citations

This map shows the geographic impact of Susanna M. Rybak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna M. Rybak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna M. Rybak more than expected).

Fields of papers citing papers by Susanna M. Rybak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna M. Rybak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna M. Rybak. The network helps show where Susanna M. Rybak may publish in the future.

Co-authorship network of co-authors of Susanna M. Rybak

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna M. Rybak. A scholar is included among the top collaborators of Susanna M. Rybak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna M. Rybak. Susanna M. Rybak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schirrmann, Thomas, Jürgen Krauß, Michaela A.E. Arndt, Susanna M. Rybak, & Stefan Dübel. (2008). Targeted therapeutic RNases (ImmunoRNases). Expert Opinion on Biological Therapy. 9(1). 79–95. 43 indexed citations

Krauß, Jürgen, Michaela A.E. Arndt, Stefan Dübel, & Susanna M. Rybak. (2008). Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy. Current Pharmaceutical Biotechnology. 9(3). 231–234. 13 indexed citations

Choudhry, Vidita, Mei-Yun Zhang, Igor A. Sidorov, et al.. (2007). Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology. 363(1). 79–90. 48 indexed citations

Boasso, Adriano, et al.. (2006). Ribonucleases in HIV Type 1 Inhibition: Effect of Recombinant RNases on Infection of Primary T Cells and Immune Activation-Induced RNase Gene and Protein Expression. AIDS Research and Human Retroviruses. 22(9). 897–907. 46 indexed citations

Krauß, Jürgen, Michaela A.E. Arndt, Bang K. Vu, et al.. (2005). Efficient killing of CD22+ tumor cells by a humanized diabody–RNase fusion protein. Biochemical and Biophysical Research Communications. 331(2). 595–602. 30 indexed citations

Krauß, Jürgen, Michaela A.E. Arndt, Bang K. Vu, Dianne L. Newton, & Susanna M. Rybak. (2005). Targeting malignant B‐cell lymphoma with a humanized anti‐CD22 scFv‐angiogenin immunoenzyme‡. British Journal of Haematology. 128(5). 602–609. 17 indexed citations

Arndt, Michaela A.E., Jürgen Krauß, Bang K. Vu, Dianne L. Newton, & Susanna M. Rybak. (2005). A Dimeric Angiogenin Immunofusion Protein Mediates Selective Toxicity Toward CD22+ Tumor Cells. Journal of Immunotherapy. 28(3). 245–251. 19 indexed citations

Yang, De, Qian Chen, Helene F. Rosenberg, et al.. (2004). Human Ribonuclease A Superfamily Members, Eosinophil-Derived Neurotoxin and Pancreatic Ribonuclease, Induce Dendritic Cell Maturation and Activation. The Journal of Immunology. 173(10). 6134–6142. 125 indexed citations

Newton, Dianne L., et al.. (2003). Construction and Characterization of RNase-Based Targeted Therapeutics. Humana Press eBooks. 207. 283–304. 5 indexed citations

10.

Newton, Dianne L. & Susanna M. Rybak. (2003). Construction of Ribonuclease-Antibody Conjugates for Selective Cytotoxicity. Humana Press eBooks. 25. 27–35. 3 indexed citations

11.

Newton, Dianne L., et al.. (2003). RNA Cleavage and Inhibition of Protein Synthesis by Bleomycin. Chemistry & Biology. 10(1). 45–52. 60 indexed citations

12.

Newton, Dianne L., Gurmeet Kaur, Johng S. Rhim, Edward A. Sausville, & Susanna M. Rybak. (2001). RNA Damage and Inhibition of Neoplastic Endothelial Cell Growth: Effects of Human and Amphibian Ribonucleases. Radiation Research. 155(1). 171–174. 5 indexed citations

13.

Iordanov, Mihail S., John Wong, Susanna M. Rybak, et al.. (2000). Differential Requirement for the Stress-Activated Protein Kinase/c-Jun NH2-Terminal Kinase in RNA Damage-Induced Apoptosis in Primary and in Immortalized Fibroblasts. PubMed. 4(2). 122–128. 30 indexed citations

14.

Iordanov, Mihail S., Olga P. Ryabinina, John Wong, et al.. (2000). Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis.. PubMed. 60(7). 1983–94. 117 indexed citations

15.

Rybak, Susanna M. & Dianne L. Newton. (1999). Natural and Engineered Cytotoxic Ribonucleases: Therapeutic Potential. Experimental Cell Research. 253(2). 325–335. 73 indexed citations

16.

Smith, Mark R., et al.. (1999). Cell Cycle-Related Differences in Susceptibility of NIH/3T3 Cells to Ribonucleases. Experimental Cell Research. 247(1). 220–232. 34 indexed citations

17.

Lee‐Huang, Sylvia, Hsiang-Fu Kung, Paul L. Huang, et al.. (1994). Crystallization and Preliminary X-ray Analysis of GAP 31. Journal of Molecular Biology. 240(1). 92–94. 8 indexed citations

18.

Fett, James W., Karen A. Olson, & Susanna M. Rybak. (1994). A Monoclonal Antibody to Human Angiogenin. Inhibition of Ribonucleolytic and Angiogenic Activities and Localization of the Antigenic Epitope. Biochemistry. 33(18). 5421–5427. 41 indexed citations

19.

Rybak, Susanna M., et al.. (1989). C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin. Biochemical and Biophysical Research Communications. 162(1). 535–543. 6 indexed citations

20.

Rybak, Susanna M. & Bert L. Vallée. (1988). Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNAs. Biochemistry. 27(7). 2288–2294. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact